Endocrine oncology

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study

Eur Thyroid JPublished Population-based retrospective study

Authors' conclusion

The incidence of TC has grown in the 2000-2020 period in the Balearic Islands, but MR has not changed. Beyond other factors, a significant contribution of overdiagnosis to this increased incidence is likely due to changes in the routine management of thyroid nodular disease and increased availability of neck US.

Study context

Population
Thyroid cancer (TC) incident cases from 2000 to 2020, Balearic Islands region
Participants
1,387 incident TC cases
Exposure
2010-2020 period vs 2000-2009 period
Outcome
Age-standardized incidence rate (ASIR) of TC
Follow-up
2000–2020
Methodological detailsPublic Health System database review, period comparison 2000-2009 vs 2010-2020
  • Public Health System database review
  • Period comparison 2000-2009 vs 2010-2020

Main finding

As reported in the abstract

ASIR (×105)

P < 0.001

Overall age-standardized incidence rate (ASIR) (×105)
5.01
Increment in EAPC
7.82%

Observational data: associations, not effects.

Further findings

Tumor size · reduction in tumor size

P < 0.001

Outcome2010-20202000-2009IncreaseP value
Age at diagnosisSignificant increase in 2010-202052.1147.32P < 0.001
Micropapillary TC6.31%P < 0.05

Disease-specific mortality rate

Disease-specific mortality rate (MR) remained stable (×105)
0.21

Age at diagnosis by mortality

Mean age at diagnosis for all mortality groups older than survivors (P < 0.001)

Original publication

Age-standardized incidence, mortality rate, and trend changes of thyroid cancer in the Balearic Islands during the 2000–2020 period: a population-based study. Eur Thyroid J. Published 21 April 2023. doi:10.1530/etj-22-0183

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.